The Cell Imaging Facility provides high resolution imaging services to 35 peer-reviewed investigators from 10 research Programs in all three Divisions at Fox Chase Cancer Center. Ninety-nine percent (99%) of the use in 2003 was in support of peer-reviewed, funded investigators. Recent technological advances in imaging software and hardware has made high resolution microscopy an essential and integral technology for biomedical researchers. Because of rapid technological advances, this shared Facility provides investigators access to state-of-the-art imaging equipment. This Facility not only provides essential services to existing investigators, but is also an effective recruiting tool for prospective investigators. Usage of this Facility increased from an average of 800 hours for years 1999 to 2001, to 2000 and 1,100 hours for years 2002 and 2003, respectively. The dramatic increase reflects increased needs of new and existing investigators for high resolution imaging. To accommodate users' needs, the Facility is now open 24/7 to all trained users. Since implementing these changes in May of 2004, the average monthly usage of the Facility has steadily increased from approximately 40 hours per week to approximately 80 hours per week. This Facility supports three broad categories of microscopic techniques: 1) localization of single or multiple proteins (up to three) within a cell by confocal or conventional immunofluorescence microscopy, 2) perform single cell experiments that rely on microinjection and video microscopy, 3) real-time visualization of fluorescent-tagged proteins. The equipment that supports these services includes a newly upgraded: BioRad Radiance 2000 Laser Scanning Confocal Microscope (LSCM), and two upgraded Nikon inverted microscopes that are equipped with epifluorescence optics and high sensitivity CCD cameras. Image acquisition and processing are conducted with Metamorph software. The role of Facility personnel is to provide technical assistance to users so that they become proficient with both image acquisition and processing. The Facility will also assist users in the design and implementation of imaging experiments. The Facility maintains the equipment and is responsible for incorporating and introducing new technologies to investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006927-45
Application #
7467252
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
45
Fiscal Year
2007
Total Cost
$150,342
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
073724262
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Nikonova, Anna S; Deneka, Alexander Y; Kiseleva, Anna A et al. (2018) Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD). FASEB J 32:2735-2746
Nacson, Joseph; Krais, John J; Bernhardy, Andrea J et al. (2018) BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. Cell Rep 25:1384
Singh, Tanu; Lee, Eric H; Hartman, Tiffiney R et al. (2018) Opposing Action of Hedgehog and Insulin Signaling Balances Proliferation and Autophagy to Determine Follicle Stem Cell Lifespan. Dev Cell 46:720-734.e6
Di Marcantonio, Daniela; Martinez, Esteban; Sidoli, Simone et al. (2018) Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia. Clin Cancer Res 24:608-618
Gabbasov, Rashid; Xiao, Fang; Howe, Caitlin G et al. (2018) NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice. Oncogene 37:4854-4870
Nacson, Joseph; Krais, John J; Bernhardy, Andrea J et al. (2018) BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. Cell Rep 24:3513-3527.e7
Fahl, Shawn P; Coffey, Francis; Kain, Lisa et al. (2018) Role of a selecting ligand in shaping the murine ??-TCR repertoire. Proc Natl Acad Sci U S A 115:1889-1894
Jones, Caitlin E; Hammer, Anisha M; Cho, YouJin et al. (2018) Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia 21:132-145
Shaikh, Talha; Wang, Lora S; Egleston, Brian et al. (2018) Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol 41:59-64
Campbell, Kerry S; Cohen, Adam D; Pazina, Tatiana (2018) Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma. Front Immunol 9:2551

Showing the most recent 10 out of 1280 publications